In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 


This content is currently on FREE ACCESS, enjoy another 64 days of free consultation

 

Panel discussion and conclusion - Current challenges and innovations in the treatment of mitral and tricuspid regurgitation.

Session Current challenges and innovations in the treatment of mitral and tricuspid regurgitation

Speaker Stefan Anker

Congress : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure - Treatment
  • Session type : Satellite Symposium
  • FP Number : 151
  • Organised by Charité Berlin, supported with an educational grant from Edwards
15 views
15 views

Other presentations from this session

Current challenges and innovations in the treatment of mitral and tricuspid regurgitation

  • Heart Failure 2019 - 6th World Congress on Acute Heart Failure
  • Chronic Heart Failure - Treatment
  • Satellite Symposium
  • 25 May 2019
  • 13:30 - 14:30
session 2019 2019
6

Other presentations from this speaker

no speaker photo speaker

Stefan Anker

Germany

101


Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are